| Metric | Q3 2021 | Q2 2021 | Q3 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $150M | — | — | — | — |
| Op. Income | $7M | — | — | — | — |
| Gross Margin | 59.2% | — | — | — | — |
| Net Margin | 4.7% | — | — | — | — |
| EPS (Diluted) | $0.02 | — | — | — | — |
| Free Cash Flow | -$386M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $150M |
| Cost of Revenue | $61M |
| GROSS PROFIT | $89M |
| R&D Expenses | $0 |
| Selling & Marketing | $8M |
| General & Administrative | $62M |
| SG&A Expenses | $70M |
| Other Expenses | $12M |
| Operating Expenses | $82M |
| Cost & Expenses | $143M |
| OPERATING INCOME | $7M |
| Interest Income | $74M |
| Interest Expense | $28M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $114.6K |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $6M |
| EBIT | $7M |
| EBITDA | $13M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $150M |
| Cost of Revenue | $61M |
| GROSS PROFIT | $89M |
| R&D Expenses | $0 |
| Selling & Marketing | $8M |
| General & Administrative | $62M |
| SG&A Expenses | $70M |
| Other Expenses | $12M |
| Operating Expenses | $82M |
| Cost & Expenses | $143M |
| OPERATING INCOME | $7M |
| Interest Income | $74M |
| Interest Expense | $28M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $114.6K |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $6M |
| EBIT | $7M |
| EBITDA | $13M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $7M |
| Depreciation & Amortization | $6M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $15M |
| Change in Working Capital | -$413M |
| OPERATING CASH FLOW | -$384M |
| Capital Expenditure | -$1M |
| Acquisitions (Net) | -$680.2K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$943M |
| NET CASH FROM INVESTING | -$944M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$1.1B |
| Common Dividends Paid | -$2M |
| Other Financing Activities | $1.4B |
| NET CASH FROM FINANCING | $277M |
| FREE CASH FLOW | -$386M |
| Net Change in Cash | -$1.1B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $846M |
| Short-Term Investments | $2.4B |
| Net Receivables | $184M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $3.4B |
| PP&E (Net) | $7M |
| Goodwill | $16M |
| Intangible Assets | $61M |
| Long-Term Investments | $3.1B |
| Tax Assets | $0 |
| Other Non-Current Assets | $146M |
| TOTAL NON-CURRENT ASSETS | $3.3B |
| TOTAL ASSETS | $6.8B |
| Account Payables | $0 |
| Short-Term Debt | $144M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $4.1B |
| TOTAL CURRENT LIABILITIES | $4.3B |
| Long-Term Debt | $628M |
| Deferred Revenue NC | $12M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $154M |
| TOTAL NON-CURRENT LIABILITIES | $794M |
| TOTAL LIABILITIES | $5.0B |
| Common Stock | $1.7B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | -$7M |
| Accum. Other Comp. Income | -$17M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.7B |
| Minority Interest | $14M |
| TOTAL EQUITY | $1.7B |
| TOTAL LIABILITIES & EQUITY | $6.8B |
| Total Debt | $773M |
| Net Debt | -$73M |
